Sugi Predict

Sugi Predict / Compounds / SCHEMBL200466

SCHEMBL200466

SCHEMBL200466

CC(C)(C)c1cc(C2CCCCC2)c(O)c(C2CCCCC2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 5/20 0.45
▸ CYP2C19 P33261 5/20 0.45
▸ CYP1A2 P05177 4/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ TSHR P16473 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ GABRA1 P14867 1/20 0.40
▸ GABRB2 P47870 1/20 0.40
▸ CNR1 P21554 1/20 0.38
▸ EPHX1 P07099 1/20 0.37
▸ EPHX2 P34913 1/20 0.37
▸ NUDT1 P36639 1/20 0.36
▸ BACE1 P56817 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16860599 0.98 CYP2D6 (0.43) CYP2D6CYP2C19CYP1A2CYP2C9TSHR
SCHEMBL9655970 0.89 KDM4E (0.42) CYP2D6CYP2C19CYP1A2CYP2C9TSHR
SCHEMBL11310233 0.87 CYP2D6 (0.40) CYP2D6CYP2C19CYP1A2CYP2C9TSHR
SCHEMBL11413208 0.87 CYP2C19 (0.49) CYP2D6CYP2C19CYP1A2CYP2C9TSHR
SCHEMBL11629893 0.86 ALOX15 (0.42) CYP2D6CYP2C19CYP1A2CYP2C9TSHR
SCHEMBL11775718 0.85 KDM4E (0.46) CYP2D6CYP2C19CYP1A2CYP2C9TSHR
SCHEMBL29229338 0.85 CA1 (0.39) CYP2D6CYP2C19CYP1A2CYP2C9TSHR
SCHEMBL11316008 0.84 CYP2D6 (0.38) CYP2D6CYP2C19CYP1A2CYP2C9TSHR
SCHEMBL11327360 0.84 CYP2C19 (0.47) CYP2D6CYP2C19CYP1A2CYP2C9TSHR
SCHEMBL14702160 0.84 CYP2D6 (0.48) CYP2D6CYP2C19CYP1A2CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230023-B2 Color converter BASF SE (DE) 2019-03-12 — — US disclosed
EP-2718395-B1 Novel illumination device comprising a colour converter BASF SE (DE) 2018-02-28 — — EP disclosed
US-20160284947-A1 NOVEL COLOR CONVERTER BASF SE (DE) 2016-09-29 — — US disclosed
US-9406848-B2 Color converter BASF SE (DE) 2016-08-02 — — US disclosed
EP-2307507-B1 NEW AZIDE SUBSTITUTED NAPHTHYLENE OR RYLENE IMIDE DERIVATIVES AND THEIR USE AS REAGENTS IN CLICK-REACTIONS BASF SE (DE) 2016-04-20 — — EP disclosed
US-8921558-B2 Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions BASF SE (DE) 2014-12-30 — — US disclosed
US-8802852-B2 Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions BASF SE (DE) 2014-08-12 — — US disclosed
EP-2718395-A1 NOVEL COLOR CONVERTER BASF SE (DE) 2014-04-16 — — EP disclosed
US-20140080220-A1 Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions BASF SE (DE) 2014-03-20 — — US disclosed
US-20140073059-A1 Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions BASF SE (DE) 2014-03-13 — — US disclosed
US-7192696-B2 Image forming method using photothermographic material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-03-20 — — US disclosed
US-20070054225-A1 SILVER SALT PHOTOTHERMOGRAPHIC DRY IMAGING MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-03-08 — — US disclosed
US-20070054225-A1 SILVER SALT PHOTOTHERMOGRAPHIC DRY IMAGING MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-03-08 — — US disclosed
US-7175978-B2 Silver salt photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-02-13 — — US disclosed
US-7175978-B2 Silver salt photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-02-13 — — US disclosed
US-7163782-B2 Photothermographic imaging material KONICA MINOLTA HOLDINGS, INC. (JP) 2007-01-16 — — US disclosed
US-7163782-B2 Photothermographic imaging material KONICA MINOLTA HOLDINGS, INC. (JP) 2007-01-16 — — US disclosed
US-20070003886-A1 SILVER SALT PHOTOTHERMOGRAPHIC DRY IMAGING MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-01-04 — — US disclosed
US-20070003886-A1 SILVER SALT PHOTOTHERMOGRAPHIC DRY IMAGING MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-01-04 — — US disclosed
US-3991139-A NORBORNENE DERIVATIVES, PHENOLS, ESTER THIOETHERS SHOWA DENKO KABUSHIKI KAISHA (JA) 1976-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140080220-A1 Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions NANS, NANP, GNE CYP2D6 1577/4885CYP2C19 456/4885CYP1A2 1363/4885
US-20140073059-A1 Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions NANS, NANP, GNE CYP2D6 1577/4885CYP2C19 456/4885CYP1A2 1363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.